We are pleased to report that 2002 was a year of significant progress in establishing GlaxoSmithKline as one of the world’s leading pharmaceutical companies.

Our archive of Annual Reports and Corporate Responsibility Reports dating back to 2000.

The case began in 2002, when GSK sent experts to fix problems cited by the FDA. The lead inspector recommended recalls of defective products, but they were not authorised; she was …

Products – Consumer Healthcare In 2002, GlaxoSmithKline Consumer Healthcare introduced two GlaxoSmithKline’s principal consumer healthcare products are new prescription to over-the …

GlaxoSmithKline plc, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer …

GSK Annual Report Read more about glaxosmithkline, financial, share, shares, assets and december.

Feb 7, 2002 · GlaxoSmithKline (GSK) remains at the forefront of this effort, and is the only company conducting research and development into the prevention and treatment of all three …

We are pleased to report that 2002 was a year of significant progress in establishing GlaxoSmithKline as one of the world’s leading pharmaceutical companies. We achieved …

Spawned by the press coverage of vaccine risks and the ongoing litigation, vaccine sales fell off dramatically in 2001. On 26 February 2002 GlaxoSmithKline decided to withdraw LYMErix™ …

In July, following the launch in the USA of the first generic version of Augmentin, we confirmed our revised business performance forecast for earnings per share (EPS) growth of at least ten per …